People: Glenmark Pharmaceuticals Ltd (GLEN.NS)
24 May 2019
Mr. Glenn Mario Saldanha serves as Executive Chairman of the Board, Chief Executive Officer, Managing Director of Glenmark Pharmaceuticals Ltd. Mr. Saldanha joined Glenmark in 1998 as Director and took over as Managing Director & CEO in 2000. He transformed Glenmark into a truly global organisation with revenue over a billion dollar. Under his leadership, Glenmark has evolved from an Indian branded generics business into a research-driven and innovation-led organisation. Mr. Saldanha’s vision is to discover, develop and take to market India's first innovative drug for the entire world.
|Total Annual Compensation, INR||149,100,000|
|Restricted Stock Award, INR||--|
|Long-Term Incentive Plans, INR||--|
|All Other, INR||12,520,000|
|Fiscal Year Total, INR||161,620,000|